We previously found a relative sparing of somatostatin and neuropeptide Y neurons 1 week after producing striatal lesions with NMDA receptor agonists. These results are similar to postmortem findings in Huntington's disease (HD), though in this illness there are two-to threefold increases in striatal somatostatin and neuropeptide Y concentrations, which may be due to striatal atrophy. In the present study, we examined the effects of striatal excitotoxin lesions at 6 months and 1 yr, because these lesions exhibit striatal shrinkage and atrophy similar to that occurring in HD striatum. At 6 months and 1 yr, lesions with the NMDA receptor agonist quinolinic acid (QA) resulted in significant increases (up to twofold) in concentrations of somatostatin and neuropeptide Y immunoreactivity, while concentrations of GABA, substance P immunoreactivity, and ChAT activity were significantly reduced.
In contrast, somatostatin and neuropeptide Y concentrations did not increase 6 months after kainic acid (KA) or cy-amino-3-hydroxy-&methyl-isoxazole4-propionic acid (AMPA) lesions. At both 6 months and 1 yr, QA lesions showed striking sparing of NADPH-diaphorase neurons as compared with both AMPA and KA lesions, neither of which showed preferential sparing of these neurons. Long-term QA lesions also resulted in significant increases in concentrations of both 5-HT and 5-hydroxyindoleacetic acid (HIAA), similar to findings in HD. Chronic QA lesions therefore closely resemble the neurochemical features of HD, because they result in increases in somatostatin and neuropeptide Y and in 5-HT and HIAA. These findings strengthen the possibility that an NMDA receptor-mediated excitotoxic process could play a role in the pathogenesis of HD.
Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disorder that usually begins in midlife and is characterized by involuntary choreiform movements, cognitive impairment, and emotional disturbance (Bruyn, 1968) . The major site of pathology in HD is the striatum, where up to 90% of the neurons may be depleted (Vonsattel et al., 1985) . Within the striatum there is differential vulnerability of neuronal populations. Striatal medium-sized spiny neurons containing the neurochemical markers GABA, substance P, dynorphin, and enkephalin are preferentially affected (Beal and Martin, 1986; Ferrante et al., 1987b; Beal et al., 1988b) . In contrast, mediumsized aspiny neurons containing the neuropeptides somatostatin and neuropeptide Y, and large aspiny neurons containing ChAT activity, are spared (Dawbam et al., 1985; Ferrante et al., 1985 Ferrante et al., , 1987a Beal et al., 1988b) . Dopaminergic and serotonergic afferent projections are also spared (Spokes, 1980; Beal et al., 1990b) . A suitable animal model of HD must replicate these features. Initial studies with kainic acid (KA)-induced lesions showed a striking resemblance to HD (Coyle and Schwartz, 1976; McGeer and McGeer, 1976) . Intrastriatal injections resulted in neuronal loss and gliosis, with reductions in markers of intrinsic striatal neurons, yet a preservation ofdopaminergic afferents. We found, however, that these lesions were an imperfect model of HD, because they resulted in a significant depletion of somatostatin levels and a loss of somatostatin neurons . We subsequently found that lesions produced by NMDA receptor agonists such as quinolinic acid (QA) provided a better model of HD, because they result in relative sparing of somatostatin and neuropeptide Y levels, despite significant depletions of both GABA and substance P levels (Beal et al., 1986a (Beal et al., , 1989b . In HD, however, there are two-to threefold increases in concentrations of somatostatin and neuropeptide Y, rather than the mere preservation of levels observed 1 week after lesions with NMDA receptor agonists (Beal et al., 1989b) . It is possible that the increased levels reflect preservation of somatostatin-neuropeptide Y neurons, in combination with striatal atrophy and shrinkage. Following long-term excitotoxin lesions, there are marked striatal shrinkage and atrophy (Zaczek et al., 1978; Isacson et al., 1984 Isacson et al., , 1985 Bjorklund et al., 1986) . In the present study, we therefore examined the effects of lesions at both 6-month and I-yr survival times.
Materials and Methods
KA and QA were obtained from Sigma (St. Louis, MO), while a-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) was obtained from Research Biochemicals (Wayland, MA). Male Sprague-Dawley rats (Charles River) weighing 150-l 75 gm were anesthetized with pentobarbital (50 mg/kg, i.p.). Compounds were dissolved in phosphatebuffered saline (pH, 7.4) and were injected in a volume of 1 ~1 into the left striatum at the coordinates 8.4 mm anterior, 2.6 mm lateral, and 4.5 mm ventral to the dura (Beal et al., 1989b) . Injections were made with a lo-r1 Hamilton syringe fit with a 30-gauge blunt-tipped needle. The QA lesions resulted in significant increases in both somatostatin (XI) and neuropeptide Y (NPYLI) concentrations while substance P (SPLl), GABA, taurine, and ChAT activity were significantly reduced. Neither KA nor AMPA lesions resulted in significant increases in somatostatin or neuropeptide Y concentrations. *, P < 0.05; **, P < 0.0 1; ***, P < 0.001.
All injections were made over 1 min, and the needle was left in place for a further 2 min before being slowly withdrawn. Three groups of eight animals were lesioned with QA (240 nmol), AMPA (22.5 nmol), or KA (7.5 nmol). These animals were killed 6 months after lesions were produced. Two additional groups of eight animals lesioned with 240 nmol of QA were allowed to survive for 1 week or 1 yr. Following death, the brains were chilled, and the anterior striatum and overlying cerebral cortex were dissected from a 2-mmthick slice, as previously described (Beal et al., 1986a) . Care was taken to exclude the globus pallidus. The left and right striata were placed in 1 ml chilled 0.1 N HCl. In the animals that survived for 1 yr, the midbrain (substantia nigra) was also dissected. Tissue samples were subsequently sonicated, extracted, and assayed for somatostatin-like immunoreactivity, neuropeptide Y-like immunoreactivity, substance P-like immunoreactivity, and GABA as previously described (Arnold et al., 1982; Beal et al., 1986b Beal and Mazurek, 1987; Ellison et al., 1987a) . Monoamines and their metabolites were measured by high-performance liquid chromatography with 16-electrode electrochemical detection (ESA CEAS, 55-0650; Matson et al., 1987) . Kynurenic acid was measured by highperformance liquid chromatography with fluorescence detection (Swartz et al., 1990) . Choline acetyltransferase activity measurements were made using the Fonnum method (Fonnum, 1969) . Protein measurements were made on the sonicate using a fluorometric assay (Bohlen et al., 1973) . The neurochemical measurements were compared with the unlesioned (control) side and are expressed as percentages of control. We have previously found that the right (control) values do not differ from saline controls (Beal et al., 1989b) . The results are expressed as the mean + standard error of the mean. Comparisons were made using Student's t test (two-tailed) or one-way analysis of variance (ANOVA).
A total of 24 animals were used for histologic studies. Six animals with QA lesions and three each with either AMPA or KA lesions were examined at 6 months. Three additional groups of four animals were lesioned with QA, KA, or AMPA and were examined at 1 yr. Initially there were equal numbers in the 1 -yr lesion groups, but only two KAand two AMPA-lesioned animals survived. Animals were killed using deep anesthesia with pentobarbital and perfused via an intracardiac cannula with 0.25% sodium nitrite in 0.9% saline followed by fixation with 4% paraformaldehyde and 0.02% glutaraldehyde in 0.1 M phosphate buffer (pH, 7.3). Brains were postfixed overnight and then removed, blocked and .washed in phosphate buffer, and cut at 50-pm intervals with a vibratome. Sections were then stained for NADPHdiaphorase in combination with Nissl, or for NADPH-diaphorase in combination with immunocytochemical staining for Met-enkephalin (ENK), as previously described (Beal et al., 1989b) .
Examination ofthe lesions at both 6 months and 1 yr showed a marked shrinkage of the lesioned striatum. Total protein measurements on the side of the lesion were reduced by approximately 50%. The large lesion core, in which there are intense gliosis and few remaining neurons at 1 week, was largely resorbed. The needle track and a small surrounding necrotic region could usually be identified. This was surrounded by a large region of partial neuronal loss and gliosis, which we term the transition zone. This extended to an area of relatively normal-appearing striatum adjacent to the corpus callosum at the periphery of the lesion. Within the transition zone, neuronal counts were made by two independent observers. A 350 x 500-pm field at 250x magnification was counted, using an eyepiece graticule. Fields in the transition zone of the lesioned striatum were compared with fields in the same location in the contralateral control (unlesioned) striatum. Counts were made in six fields in each animal and were averaged. Counts were expressed as the ratio of NADPH-diaphorase-reactive neurons to total neurons (Nissl stained) or to the number of Met-enkephalin neurons. Statistical comparisons were made by ANOVA with post hoc analysis using the Sheffe F test or the nonpaired Student's t test. The results are expressed as the mean + standard error of the mean.
Results
The neurochemical effects of QA, KA, and AMPA lesions at 6 months are shown in Figure 1 . We chose doses of each toxin that our previous experience indicated would produce lesions of comparable size (Beal et al., 1989b) . Nevertheless, in the present experiments the lesions following KA and AMPA were less severe than those produced by QA, because neither substance P nor GABA were significantly reduced at 6 months following the lesions. Histologic evaluation verified that lesions were present in all groups. The absence of significant reductions in GABA and substance P appeared to be due to the overall shrinkage of the striatum following the lesions.
The QA lesions resulted in significant depletions of both substance P and GABA of about 40%. Taurine concentrations were reduced approximately 20%. Somatostatin and neuropeptide Y concentrations were significantly increased by 115% and 41%, respectively. In contrast there were no significant increases following KA or AMPA lesions, and indeed, AMPA lesions re-q sanotostotin-like ImmunonoctMty 25 n " Striatum Midbrain Figure 3 . Effects of QA striatal lesions at 1 yr. Somatostatin and neuropeptide Y concentrations were significantly increased in the striatum, while GABA and substance P were significantly reduced in both the striatum and midbrain. There were no significant changes in overlying cerebral cortex. *, P < 0.05; **, P < 0.0 1.
sulted in a significant, 29%, reduction in neuropeptide Y concentrations. There were no significant changes in levels of neuropeptides or amino acid neurotransmitters in the overlying cerebral cortex (Fig. 2) . Striatal ChAT activity was significantly decreased by 52% following QA lesions and by 36% following KA lesions. The neurochemical effects of QA lesions at 1 yr are shown in Figure 3 . Similar to the 6-month lesions, there were significant 40% reductions in GABA and substance P, while somatostatin and neuropeptide Y were significantly increased by 41% and 74%, respectively. There were no significant changes in neurochemical markers in the overlying cortex, while both substance P and GABA concentrations were significantly reduced in the midbrain ipsilateral to the striatal lesions.
Changes in dopamine (DA), 5-HT, and their metabolites were compared in QA lesions at 1 week and at 1 yr (Fig. 4) . The 1 -week lesions resulted in significant increases in homovanillic acid (HVA) and 5hydroxyindoleacetic acid (HIAA), yet no changes in DA and 5-HT concentrations, resulting in significant increases in the ratios of HVA and HIAA to their parent compounds. At 1 yr, there were significant increases in concentrations of both 5-HT and HIAA, but no significant changes in DA or HVA. Similar changes were observed following QA, AMPA, and KA lesions at 6 months (Fig. 5 ). There were no significant changes in concentrations of uric acid, xanthine, tyrosine, tryptophan, or kynurenine at 6 months in the animals lesioned with QA and KA (data not shown). Kynurenic acid concentrations were significantly increased in animals lesioned with QA at 6 months. The concentration on the unlesioned side was 273.3 -t 40.9 fmol/mg protein, compared with 590.8 f 127.9 fmol/mg protein on the lesioned side (n = 7; p < 0.03).
Chronic QA lesions at both 6 months and 1 yr resulted in marked striatal atrophy and shrinkage. No discernable histologic or morphologic differences could be identified between 6-month and 1-yr QA lesions. The marked atrophy is shown histologically in Figure 6 . Despite marked gliosis and neuronal depletion, there was a relative preservation of NADPH-diaphorase neurons within regions that showed a depletion of Nissl- Figure 4 . Effects of QA striatal lesions at 1 week and 1 yr on monoamines and their metabolites. At 1 week, both HVA and HIAA were significantly increased, with no change in DA ant 5-HT, whereas at 1 yr only HIAA and 5-HT were significantly increased. *, P < 0.05.
stained neurons (Fig. 7A-D) . KA lesions at 6 months and 1 yr showed a comparable degree of striatal atrophy (Fig. 6 ). In contrast to QA lesions, these lesions did not show relative sparing of NADPH-diaphorase neurons within the areas in which there was a depletion of Nissl-stained neurons ( Fig. 8A-D) . A camera lucida drawing of NADPH-diaphorase neurons in 6-month KAand QA-lesioned striata is shown in Figure 9 , demonstrating relative sparing of NADPH-diaphorase following the QA lesion. In addition, there was qualitative sparing of large neurons with QA, KA, and AMPA lesions, though this was not quantitated. ENK staining is a selective marker for striatal medium-sized spiny neurons, which are depleted by excitotoxin lesions. We Figure 5 . Effects of QA, KA, and AMPA striatal lesions on monoamines and their metabolites at 6 months. Significant increases in 5-HT were seen with all three compounds, while HIAA was significantly increased with both QA and IL4 lesions. *, P < 0.05; **, P < 0.01. Figure 6 . Photomicrographs of Nisslstained coronal sections of striatal lesions produced by QA (A) and IL4 (B) in rats killed at 1 yr. The notch in cortex identifies the lesioned side. Note the marked striatal atrophy in both A and B as compared to the contralateral side. Magnification, 1 x .
therefore examined whether NADPH-diaphorase neurons were spared relative to ENK-stained neurons in the 6-month lesions. Camera lucida drawings of both QA and KA lesions comparing ENK-stained neurons to NADPH-diaphorase neurons are shown in Figure 10 . The QA lesions resulted in sparing of NADPHdiaphorase neurons relative to ENK neurons; however, no such sparing was seen with the IL4 lesions. Representative sections of ENK immunocytochemistry combined with NADPH-diaphorase staining following both QA and KA lesions are shown in Tables 1  and 2 , respectively. QA lesions resulted in marked sparing, but neither IL4 nor AMPA lesions showed relative sparing of NADPH-diaphorase neurons.
Discussion
Neurodengerative illnesses such as Alzeimer's disease, Parkinson's disease, and HD are characterized by gradually evolving selective neuronal death. As yet, the mechanisms by which selective neuronal death occurs are unknown. Animal models using neurotoxins that produce similar patterns of neuronal degeneration may yield important clues to the etiology of these illnesses. In HD, much interest has been focused on the similarities between striatal lesions produced with excitatory amino acid analogs, and the neurochemical and neuropathological features of HD.
In 1976, it was demonstrated that intrastriatal injection of the powerful neuroexcitant KA leads to the degeneration of striatal neurons (Coyle and Schwartz, 1976; McGeer and McGeer, 1976) . The lesions were confined to neuronal cell bodies, did not affect traversing or afferent fibers, and appeared to spare non-neuronal elements such as glia. The parallels extended to subtle aspects of the neuropathology, such as differential sparing of large striatal neurons. It was therefore proposed that an endogenous "excitotoxin" might play a role in the pathogenesis of HD.
KA is isolated from the seaweed Diginea simplex and is not present in mammalian brain. Furthermore, we and others found that lesions with KA do not spare somatostatin-neuropeptide Y neurons, which are spared in HD (Araki et al., 1985; Beal et al., , 1986a . Recent work with excitatory amino acid analogs has focused on compounds known to be present in mammalian brain. Schwartz and colleagues found that lesions with Figure 7 . Combined Nissl and NADPH-diaphorase staining of a 1-yr QA-lesioned rodent striatum (Fig. 6A ) in A and C with corresponding areas of contralateral unlesioned striatum in B and D. In A, a needle track fir right) is surrounded by a small lesion core that extends into a region of marked neuronal depletion (transition zone) in which NADPH-diaphorase neurons (dark blue neurons with dendritic arbors) are strikingly preserved. This region continues into a more normal zone Cfar left) in which Nissl-stained neurons appear in the same frequency as in the contralateral side. A higher-power photomicrograph of the transition zone is represented in C, with control striatum in D. Combined ENK and NADPH-diaphorase staining of QA-lesioned striatum is demonstrated in E, and contralateral unlesioned striatum in F. Brown perikarya are ENK-positive neurons, while dark blue neurons with secondary and tertiary dendritic arbors are NADPH-diaphorase neurons. There is a significant reduction of both neuronal and neuropil ENK staining in the QA-lesioned striatum as compared to the contralateral side with a preservation of NADPH-diaphorase neurons. Magnification: A and B, 4 x ; C-F, 10 x .
the tryptophan metabolite QA resulted in selective neuronal progressive degenerative illness. The acute injection of QA or damage similar to that seen in HD (Schwartz et al., 1983 (Schwartz et al., , 1984 .
other excitotoxins results in a high concentration of the exciAlthough QA lesions have been used to model HD, they are totoxin, which then diffuses outwards, producing a concentranot ideal in that one is using an acute injection to mimic a slowly tion gradient. The area immediately surrounding the injection Figure 8 . Combined Nissl and NADPH-diaphorase staining of a I-yr KA-lesioned rodent striatum (Fig. 6B ) in A and C, with corresponding areas of the contralateral unlesioned striatum in B and D. There is marked neuronal loss without NADPH-diaphorase cell sparing as compared to QA (Fig. 7A, C) . Combined ENK and NADPH-diaphorase staining in E demonstrates that both neurochemical subsets of striatal neurons are depleted. The contralateral unlesioned striatum is shown in F. Magnification: A and B, 4 x ; C-F, 10 x.
site is characterized by intense gliosis and indiscriminate desponse studies of excitotoxins and histologic studies to dempletion of all neuronal types. We have termed this zone the onstrate relative sparing with medium-sized aspiny neurons lesion core (Beal et al., 1989b) . Surrounding this zone is an area containing somatostatin and neuropeptide Y (which are of gliosis and partial neuronal loss we have termed the transition NADPH-diaphorase positive) within the transition zone of QA zone, because it extends to the region in which neurons appear lesions (Beal et al., 1986a (Beal et al., , 1989b . We found that lesions with undamaged. We have utilized both neurochemical dose-rethe NMDA receptor agonists L-homocysteic acid and N-methyl- D,L-aspartate also produce relative sparing of NADPH-diaphorase neurons (Beal et al., 1989b (Beal et al., , 1990a . Dose-response studies in both striatal cell cultures and organotypic striatal cultures have confirmed a relative, but not absolute, sparing of NADPHdiaphorase neurons following lesions with NMDA receptor agonists (Koh et al., 1986; Koh and Choi, 1988; Whetsell and Christie-Pope, 1988) . The relative sparing of somatostatin-neuropeptide Y (NADPH-diaphorase) neurons following QA lesions was questioned in two histologic studies, which showed a marked loss of these neurons in the centers of the lesions (Boegman et al., 1987; Davies and Roberts, 1987) . We do not dispute a loss of these neurons in the lesion core, and our own studies are in accord with this. We do, however, contend that there is a relative sparing of these neurons in the transition zone, as compared with both enkephalin-immunoreactive neurons and Nissl stained neurons, following lesions with NMDA receptor agonists (Beal et al., 1986a (Beal et al., , 1989b . The present studies show this more clearly than do studies with l-week survival time. At 6 months and 1 yr after the lesions there is marked striatal shrinkage, and much of the lesion core is resorbed (ficzek et al., 1978; Isacson et al., 1985; Bjorklund et al., 1986; Roberts and DiFiglia, 1989) , as shown in Figure 6 . There is a relative enrichment of the transition zone in which there is partial neuronal loss and relative neuronal sparing. This results in a more striking sparing of the A B Figure 9 . Camera lucida drawings of 1-yr KA-(A) and QA-lesioned (B) caudate-putamen (0) at the level of the anterior commissure (UC). The left CP has been lesioned. There is a paucity of surviving NADPHdiaphorase neurons (black dots) in KA-lesioned striatum, while they are relatively spared in the QA-lesioned striatum. Note the enlarged lateral ventricle (IV) in both cases. NADPH-diaphorase neurons, which are significantly increased in density within this region (Figs. 7,9 ; Tables 1,2 ). In contrast, no significant increase in density of NADPH-diaphorase neurons is seen following either KA or AMPA lesions. In addition to the present results, we have recently confirmed relative spring of NADPH-diaphorase neurons following NMDA agonist lesions in a double-blind study, with a novel type of lesion in which sparing occurs throughout much of the lesioned area, and with electronmicroscopy in primates (M. F. Beal, R. J. Ferrante, and P. B. Cipolloni, unpublished observations). We therefore believe that there is strong evidence to show a relative sparing of NADPH-diaphorase neurons with NMDA receptor-mediated striatal lesions. It should be emphasized, however, that even with 6-month and I-yr lesions, there are regions of the lesions in which NADPH-diaphorase neurons are depleted. It is the areas outside the lesion core, in which the sparing of NADPH-diaphorase neurons is marked, that closely resemble HD.
One possible explanation for the sparing of NADPH-diaphorase neurons following NMDA striatal lesions is that these neurons receive fewer excitatory amino acid afferents and/or exhibit fewer NMDA receptors than other neurons. Consistent with this, a recent ultrastructural study ofthe neuropeptide Y neurons in the striatum showed that synaptic inputs to proximal dendrites and somata were rare, as compared with neighboring neurons (Aoki and Pickel, 1989) . We found that NMDA receptor-induced early gene expression is reduced in striatal NADPHdiaphorase neurons (N. W. Kowall and M. F. Beal, unpublished observations), consistent with fewer numbers of NMDA receptors. It is also possible that NADPH-diaphorase neurons could differ in calcium buffering capacity, or in ability to resist oxidative stress.
Although 1 -week lesions with NMDA receptor agonists result in relative sparing of somatostatin and neuropeptide Y concentrations, as compared to those of GABA and substance P, they do not result in significant increases in concentrations as seen in HD. At both 6 months and 1 yr, however, we observed significant increases in both somatostatin and neuropeptide Y concentrations, despite significant reductions in both GABA and substance P concentrations in the striatum and midbrain. In contrast, neither KA nor AMPA lesions resulted in significant increases in either somatostatin or neuropeptide Y concentrations at 6 months. The finding of significant increases in somatostatin and neuropeptide Y concentrations with long-term QA lesions is probably due to the increased density of surviving somatostatin-neuropeptide Y neurons, and perhaps afferents as well, in the shrunken striatum. Similar mechanisms may occur in HD. Although it has recently been shown that excitatory amino acids can increase somatostatin mRNA (Pate1 et al., 1989) , it is unlikely that such an increase would persist for 6 months or 1 yr after a lesion (Meyer et al., 1988) .
There were no significant changes in somatostatin, neuropeptide Y, substance P, and glutamate concentrations in cerebral cortex overlying the lesions. In HD cerebral cortex, we found small increases in neuropeptide Y and somatostatin concentrations, yet no change in glutamate concentrations (Ellison et al., 1987b; Beal et al., 1988b) , consistent with histologic preservation of neuropeptide Y neurons and loss of pyramidal neurons (Cudkowicz and Kowall, 1990) . It is unknown whether the degeneration of cortical pyramidal neurons in HD is a primary effect of the illness or is secondary to striatal degeneration. The present findings argue against the cortical changes being secondary, because they were not observed following long-term striatal excitotoxin lesions.
It is of interest that ChAT activity remained reduced at 6 months following both QA and KA lesions. This is consistent with the results of Zaczek et al. (1978) with KA lesions at 1 yr. It is a paradoxical result because large striatal aspiny neurons containing ChAT activity are relatively spared by both QA and KA lesions at 1 week (Beal et al., 1989b; Roberts and DiFiglia, 1989) . Large neurons were also spared by both types of lesions in the present study. This finding parallels our observations in HD in which there is a preservation of cholinergic perikarya despite a loss of ChAT activity (Ferrante et al., 1987a) . The explanation for this discrepancy may be that there are retrograde changes in cholinergic axon terminals, with a consequent depletion of enzyme activity, despite preserved neuronal perikarya. A loss of ChAT axon terminals within the lesion core has been observed (Roberts and DiFiglia, 1989) . The striatal cholinergic neurons are known to have extensive axonal arborizations synapsing on dendritic spines and shafts of mediumsized spiny projection neurons (DiFiglia, 1987; Izzo and Bolam, 1988) which may make them vulnerable to retrograde degeneration.
Neurochemical studies of HD striatum show either no alteration or small increases in DA concentrations (Spokes, 1980; Kish et al., 1987; Beal et al., 1990b) . HVA concentrations are unchanged, while both 5-HT and HIAA concentrations are significantly increased (Spokes, 1980; Kish et al., 1987; Reynolds and Pearson, 1987; Beal et al., 1990b) . One-week lesions with QA did not replicate these findings, because both HVA and HIAA were significantly increased, yet there were no significant changes in DA and 5-HT concentrations. Similar observations have been made at 10 d after QA and KA lesions (Sperk et al., 1981; Aldinio et al., 1985; Mazzari et al., 1986) . In contrast, at both 6 months and 1 yr, there were significant increases in both 5-HT and HIAA, yet no change in DA or HVA, similar to findings in HD. Because there is marked striatal shrinkage both in HD and following chronic excitotoxin lesions, the unchanged DA levels may actually represent a loss of total striatal DA, consistent with a dying back of striatal DAergic afferents (Schwartz et al., 1980; Isacson et al., 1985) , which is also seen in HD (Ferrante and Kowall, 1987) . The difference between the effects of striatal lesions on DA and 5-HT may reflect synaptic contacts. Almost all DA terminals form synapses on striatal neurons (Pickel et al., 1981) whereas some 5-HT boutons do not appear to form morphologically defined synapses (Soghomonian et al., 1989) . Alternatively, 5-HT terminals may be more extensively collateralized, making them less susceptible to retrograde degeneration.
Although QA lesions replicate many of the neurochemical features of HD, concentrations of QA are unchanged in HD postmortem tissue and cerebrospinal fluid (Reynolds et al., 1988; Schwartz et al., 1988; Heyes et al., 1991) . In addition, we found that lesions with NMDA receptor agonists other than QA also result in relative sparing of somatostatin-neuropeptide Y neurons (Beal et al., 1989b (Beal et al., , 1990a . We therefore view QA lesions as a model of HD, suggesting that there may be an NMDA receptor-mediated excitotoxic process. Consistent with this, it has recently been shown that NMDA receptors are preferentially lost in HD striatum . One potential mechanism that could result in overactivation of NMDA receptors is a deficiency of kynurenic acid, which is an antagonist at the glycine allosteric site on the NMDA receptor (Danysz et al., 1989; Kessler et al., 1989) . We recently found a significant decrease in kynurenic acid concentrations in HD putamen and cerebrospinal fluid (Beal et al., 1990b) . The present results show that kynurenic acid concentrations are increased with long-term excitotoxin lesions, consistent with a glial localization (Turski et al., 1989) .
Chronic (long-term) lesions with NMDA receptor agonists, such as QA, provide a neurochemical model that closely mimics the alterations observed in HD striatum. Not only is there a depletion of markers of spiny neurons (GABA and substance P), but there are also significant increases in neurochemical markers of aspiny neurons (somatostatin and neuropeptide Y) and a depletion of ChAT activity, similar to changes observed in HD. In addition, the long-term lesions result in changes in monoamine concentrations identical to those seen in HD. Excitotoxin lesions are also neurochemically similar to HD in a number of other respects: Striatal QA lesions result in increased concentrations of neurotensin, similar to changes seen in HD (Masuo et al., 1990) . Following QA lesions, there is a preferential loss of NMDA receptors as compared with non-NMDA receptors . There are also depletions of DA, GABA, benzodiazepine, opiate, 5-HT, and muscarinic receptors (Schwartz et al., 1977 (Schwartz et al., , 1980 Hruska et al., 1978; Zaczek et al., 1978; Young et al., 1984; Joyce and Marshall, 1987) similar to findings in HD (Penney and Young, 1982; Whitehouse et al., 1985; Waeber and Palacios, 1989) . In rats, motor hyperactivity and learning deficits have been observed (Sanberg et al., 1978 (Sanberg et al., , 1989 Mason and Fibinger, 1979; Deckel et al., 1983; Isacson et al., 1986) . There are also reductions in striatal glucose metabolism (Isacson et al., 1984) , as seen in HD (Young et al., 1986) . We and others have recently found that excitotoxin lesions in primates result in DA agonist-inducible chorea (Kanazawa et al., 1985; Hantraye et al., 1988; Beal et al., 1989a) . These similarities between lesions induced by NMDA receptor agonists and HD strengthen the possibility that an NMDA receptor-mediated excitotoxic mechanism may be involved in the pathogenesis of HD.
